Weekly signal · CRS · Industrials

Carpenter Technology Corporation (CRS) posts 16.1% weekly gain in specialty-metals advance

The move keeps the industrials stock in focus as the longer weekly setup continues to strengthen.

Carpenter Technology Corporation
Latest561.49 USD
1W move16.1%
Volume1.2x
TrendActive
Weekly market chart for Carpenter Technology with specialty metal billets and fabrication equipment.

Market update

What happened

Carpenter Technology Corporation (CRS) closed at 561.49 USD for the week ended June 12, adding to a 37.3% four-week rise in weekly market data.

The weekly price path over 52 weeks shows the advance extending rather than reversing. Participation also supported the move, with 3.92 million shares traded versus a 13-week average of 3.35 million.

Continue your research

Explore CRS across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Interactive chartReview weekly price, Trend Line, Fair Value, volume and Relative Strength.Full weekly reportOpen the full company report, financial profile and peer comparison.Technical analysisExamine support, resistance, momentum and the current trend readings.Stage analysisSee whether the stock is basing, advancing, distributing or declining.Trend historyReview how long the current trend has persisted and where it has changed.Sector comparisonCompare sector returns, breadth, leaders and weaker areas.Industry comparisonSee how this company’s industry is performing across its members.Company factorsCompare value, quality, growth, momentum and financial strength.News sentimentSee the balance, quality and freshness of recent company coverage.Buying and selling pressureReview longer-term accumulation, distribution and reversal readings.EarningsReview report dates, estimates, past results and earnings surprises.Options activitySee options positioning, expected move and unusual trading activity.Short interestReview short positioning, crowding and possible squeeze risk.Insider transactionsSee reported purchases and sales by company directors and executives.

CRS coverage

Evidence context